NO153368B - PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE - Google Patents
PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE Download PDFInfo
- Publication number
- NO153368B NO153368B NO803229A NO803229A NO153368B NO 153368 B NO153368 B NO 153368B NO 803229 A NO803229 A NO 803229A NO 803229 A NO803229 A NO 803229A NO 153368 B NO153368 B NO 153368B
- Authority
- NO
- Norway
- Prior art keywords
- dibenz
- carboxamide
- azepine
- dihydro
- oxo
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 238000002360 preparation method Methods 0.000 title claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 18
- HQXOFJNTUXHWMC-UHFFFAOYSA-N 5-chlorobenzo[b][1]benzazepine-11-carboxamide Chemical compound C1=C(Cl)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 HQXOFJNTUXHWMC-UHFFFAOYSA-N 0.000 claims description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- ZFXVFMBOFIEPII-UHFFFAOYSA-N 1h-azepine-4-carboxamide Chemical compound NC(=O)C1=CC=CNC=C1 ZFXVFMBOFIEPII-UHFFFAOYSA-N 0.000 description 2
- ZKHZWXLOSIGIGZ-UHFFFAOYSA-N 5-methoxy-11h-benzo[b][1]benzazepine Chemical compound COC1=CC2=CC=CC=C2NC2=CC=CC=C12 ZKHZWXLOSIGIGZ-UHFFFAOYSA-N 0.000 description 2
- PIZOFBKQWNPKDK-UHFFFAOYSA-N 5-methoxybenzo[b][1]benzazepine-11-carboxamide Chemical compound COC1=CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C12 PIZOFBKQWNPKDK-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 1
- PEGGCXAMOPOILB-UHFFFAOYSA-N 1-(5,6-dibromo-5,6-dihydrobenzo[b][1]benzazepin-11-yl)ethanone Chemical compound BrC1C(Br)C2=CC=CC=C2N(C(=O)C)C2=CC=CC=C21 PEGGCXAMOPOILB-UHFFFAOYSA-N 0.000 description 1
- RFLOWQIDXYCARJ-UHFFFAOYSA-N 1-(5-bromobenzo[b][1]benzazepin-11-yl)ethanone Chemical compound C1=C(Br)C2=CC=CC=C2N(C(=O)C)C2=CC=CC=C21 RFLOWQIDXYCARJ-UHFFFAOYSA-N 0.000 description 1
- BMIBQXQBABYZOW-UHFFFAOYSA-N 1-(5-chlorobenzo[b][1]benzazepin-11-yl)ethanone Chemical compound C1=C(Cl)C2=CC=CC=C2N(C(=O)C)C2=CC=CC=C21 BMIBQXQBABYZOW-UHFFFAOYSA-N 0.000 description 1
- OSQPHLCMJMVXLB-UHFFFAOYSA-N 1-(5H-dibenzo[b,f]azepin-5-yl)ethan-1-one Chemical compound C1=CC2=CC=CC=C2N(C(=O)C)C2=CC=CC=C21 OSQPHLCMJMVXLB-UHFFFAOYSA-N 0.000 description 1
- -1 2,5- dioxo-3-chlorophenyl Chemical group 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DJQKHJIGURUVKD-UHFFFAOYSA-N 5,6-dichloro-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide Chemical compound ClC1C(Cl)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 DJQKHJIGURUVKD-UHFFFAOYSA-N 0.000 description 1
- QGKKILZRIPXDQH-UHFFFAOYSA-N 5-chloro-11h-benzo[b][1]benzazepine Chemical compound ClC1=CC2=CC=CC=C2NC2=CC=CC=C12 QGKKILZRIPXDQH-UHFFFAOYSA-N 0.000 description 1
- JDAZPRYNBAKNQG-UHFFFAOYSA-N CCOC(=O)C(=O)C(CC(=C)Cl)C1=C(C(=CC=C1)Cl)[N+](=O)[O-] Chemical compound CCOC(=O)C(=O)C(CC(=C)Cl)C1=C(C(=CC=C1)Cl)[N+](=O)[O-] JDAZPRYNBAKNQG-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- KPADFPAILITQBG-UHFFFAOYSA-N non-4-ene Chemical compound CCCCC=CCCC KPADFPAILITQBG-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- CTRLABGOLIVAIY-UHFFFAOYSA-N oxcarbazepine Chemical compound C1C(=O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 CTRLABGOLIVAIY-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
Description
Oppfinnelsens gjenstand er en ny og fordelaktig fremgangsmåte til fremstilling av 1O-okso-10,11-dihydro-5H-dibenz(b,f)asepin-5-<k>arboksamid med formel The object of the invention is a new and advantageous process for the preparation of 1O-oxo-10,11-dihydro-5H-dibenz(b,f)azepine-5-<k>arboxamide with the formula
idet fremgangsmåten er karakterisert ved at 10-klor-5H-dibenz (b, f) azepin-5- karboksamid med formel in that the method is characterized by the fact that 10-chloro-5H-dibenz (b, f) azepine-5-carboxamide with the formula
hydrolyseres ved hjelp av 90-96% svovelsyre ved en temperatur pa10-30°C. is hydrolyzed using 90-96% sulfuric acid at a temperature of 10-30°C.
Fra tysk off. skrift nr. 2.01 1 .087 er det kjent en fremgangsmåte til fremstilling av 10-okso-10,11-dihydro-5H-dibenz(b,f,)asepin-5-karboksamid idet 10-metoksy-5H-dibenz(b,f)asepin-5-karboksamid hydrolyseres ved hjelp av en mineralsyre, f.eks. fortynnet saltsyre ved tilbakeløpstemperatur. Fremstillingen av dette utgangsmaterialet foregår som angitt ved omsetning av 10-metoksy-5H-dibenz(b,f)asepin med fosgen eller tilsvarende 5-karbonylklorid og dets omsetning med ammoniakk til 10-metoksy-5H-dibenz(b,f)asepin-5-karboksamid. Det nødvendige 10-matoksy-5H-dibenz(b,f)-asepin igjen, er ifølge angivelser i belgisk patent nr. 597.793 tilgjengelige fra 5-acetyl-5H-dibenz(b,f)-asepin og det derav ved hjelp av addisjon av brom, fremstHlbare 5-acetyl-10,11-dihydro-10,11-dibrom-5H-dibenz(b,f)-asepin, dets ometning med kaliumhydroksyd til 5-acetyl-10-brom-5H-dibenz (b,f)asepin og dets reaksjoner med natriummetylat eller direkte omsetning From German off. publication no. 2.01 1.087, a method for the production of 10-oxo-10,11-dihydro-5H-dibenz(b,f,)azepine-5-carboxamide is known, wherein 10-methoxy-5H-dibenz(b, f) azepine-5-carboxamide is hydrolysed with the aid of a mineral acid, e.g. dilute hydrochloric acid at reflux temperature. The production of this starting material takes place as indicated by reaction of 10-methoxy-5H-dibenz(b,f)azepine with phosgene or corresponding 5-carbonyl chloride and its reaction with ammonia to 10-methoxy-5H-dibenz(b,f)azepine- 5-carboxamide. The necessary 10-methoxy-5H-dibenz(b,f)-azepine again, according to indications in Belgian patent no. 597,793, is available from 5-acetyl-5H-dibenz(b,f)-azepine and the derivative by means of addition of bromine, preparable 5-acetyl-10,11-dihydro-10,11-dibromo-5H-dibenz(b,f)-azepine, its transsaturation with potassium hydroxide to 5-acetyl-10-bromo-5H-dibenz (b, f)azepine and its reactions with sodium methylate or direct reaction
av overnevnte bromaddisjonsprodukt, med minst den dobbeltmolare mengde, fortrinnsvis et større overskudd av natriummetylat. of the above-mentioned bromine addition product, with at least the double molar amount, preferably a larger excess of sodium methylate.
Ulemper ved denne i og for seg allerede omstendelige fremgangsmåten til fremstilling av det nødvendige utgangsstoff, ligger spesielt også i det relativt høye forbruk av brom, som bare tjener til innføring og omdannelse av funksjonelle' grupper. Disadvantages of this, in and of itself, already cumbersome method for producing the necessary starting material, lie in particular also in the relatively high consumption of bromine, which only serves for the introduction and conversion of functional groups.
Disse ulemper unngås i forbindelse med fremgangsmåten ifølge oppfinnelsen, idet man anvender det hertil nødvendige utgangsmateriale som ifølge DOS 2.542.335 enten er tilgjengelig ved omsetning av 5-acetyl-5H-diben;z (b,f)asepin med klor til 5-acetyl-10,11-diklor-10,11, dihydro-5H-diben:z(b,f)asepin, dets omdannelse ved hjelp av en tertier organisk base, som f.eks. diisopropyletyl-amin, til 5-acetyl-10-klor-5H-dibenz(b,f)asepin, fulgt av dets hydrolyse ved hjelp av bromhydrogensyre til 10-klor-5H-dibenz(b,f)asepin, dets omsetning med fosgen til det tilsvarende 5-karbonylklorid og endelig dets reaksjon med ammoniakk, eller ved addisjon av klor til 5H-dibenz (b,f)asepin-5-karboksamid og behandling av det dannede 10,11-diklor-10,11-dihydro-5H-dibenz(b,f)-asepin-5-karboksamid, med en tertiær organisk base, som f.eks. 1,5-diasabicyklo (4,3,0)non-5-en. These disadvantages are avoided in connection with the method according to the invention, by using the necessary starting material which, according to DOS 2,542,335, is either available by reacting 5-acetyl-5H-diben;z (b,f)azepine with chlorine to 5-acetyl -10,11-dichloro-10,11, dihydro-5H-diben:z(b,f)azepine, its conversion by means of a tertiary organic base, such as diisopropylethylamine, to 5-acetyl-10-chloro-5H-dibenz(b,f)azepine, followed by its hydrolysis with hydrobromic acid to 10-chloro-5H-dibenz(b,f)azepine, its reaction with phosgene to the corresponding 5-carbonyl chloride and finally its reaction with ammonia, or by addition of chlorine to 5H-dibenz (b,f)azepine-5-carboxamide and treatment of the formed 10,11-dichloro-10,11-dihydro-5H -dibenz(b,f)-azepine-5-carboxamide, with a tertiary organic base, such as e.g. 1,5-diasabicyclo(4,3,0)non-5-ene.
Fra Heiv.chim.Acta Vol. 55, side 451-60, (1972), From Heiv.chim.Acta Vol. 55, pages 451-60, (1972),
er det kjent omdannelsen av i metylenklorid oppløst 2-okso-3-(2-nitro-3-klor-fenyl)-5-klor-5-hexensyre-etylester ved hjelp av -15°C avkjølt konsentrert svovelsyre til 2,5-diokso-3-klorfenyl)hexan-syre-etylester. it is known the conversion of 2-oxo-3-(2-nitro-3-chloro-phenyl)-5-chloro-5-hexenoic acid ethyl ester dissolved in methylene chloride by means of -15°C cooled concentrated sulfuric acid to 2,5- dioxo-3-chlorophenyl)hexane acid ethyl ester.
I J.Amer.Chem.Sos. 88, 4290-91 (1966) omtales en In J. Amer. Chem. Sos. 88, 4290-91 (1966) one is mentioned
enkel fremgangsmåte til fremstilling av cykloalkanoner av forskjellig ringstørrelse, idet man i en egnet nukleofil forbindelse innfører B-klorallylgruppen som ved hydrolyse ved hjelp av maursyre eller 90%- ig svovelsyre omdannes i det tilsvarende mettede keton. Således dannes f.eks. 1 -(2-klor-allyl)-inden ved simple method for the preparation of cycloalkanones of different ring sizes, by introducing the B-chlorallyl group into a suitable nucleophilic compound which, by hydrolysis with the aid of formic acid or 90% sulfuric acid, is converted into the corresponding saturated ketone. Thus, e.g. 1 -(2-chloro-allyl)-indene by
hjelp av 97%- ig maursyre og etterfølgende behandling med vann til 3,5-(o-fenylen)-cyklohexanon. using 97% formic acid and subsequent treatment with water to 3,5-(o-phenylene)-cyclohexanone.
I avhengighet at det anvendte utgangsmaterialstruktur, kan anvendelsen av 97%- ig svovelsyre ved 0°C være mer fordelaktig isteden for maursyre. Depending on the starting material structure used, the use of 97% sulfuric acid at 0°C may be more advantageous instead of formic acid.
Overraskende ble det nå funnet, at ved fremgangsmåten ifølge oppfinnelsen, gjennomføres hydrolysen av 10-klor-5H-diben I(b,f)asepin5-karboksamid til 10-okso-10,11-dihydro-5H-diben z(b,f)asepin-5- Surprisingly, it was now found that with the method according to the invention, the hydrolysis of 10-chloro-5H-dibene I(b,f)azepine 5-carboxamide is carried out to 10-oxo-10,11-dihydro-5H-dibene z(b,f )azepin-5-
karboksamid ved hjelp av konsentrert svovelsyre ved normaltemperaturr Med konsentrert svovelsyre forstås her 90-96%-ig fortrinnsvis 96%-ig svovelsyre.. Reaksjonstemperaturen ligger f.eks. ved 10-30°C, fortrinnsvis ved 15-25°C. carboxamide using concentrated sulfuric acid at normal temperatures By concentrated sulfuric acid is meant here 90-96% preferably 96% sulfuric acid. The reaction temperature is e.g. at 10-30°C, preferably at 15-25°C.
Det kunne ikke ventes at under betingelsene for fremgangsmåten ifølge oppfinnelsen ville urinstoff-gruppene ikke angripes, da det er kjent at urinstoff-forbindelser hydroliserer ved hjelp av vandige syrer, spesielt ved for høy temperatur. Således er det fra "Berichte der Deutschen Chemischen Gesellschaft" It could not be expected that under the conditions of the method according to the invention the urea groups would not be attacked, as it is known that urea compounds hydrolyze with the aid of aqueous acids, especially at too high a temperature. Thus it is from the "Berichte der Deutschen Chemischen Gesellschaft"
9 (1978), side 397, kjent at usymmetrisk difenyl-urinstoff ved oppvarming med svovelsyre gir en blå oppløsning, som tydeligvis forårsakes av difenyl- 9 (1978), page 397, it is known that unsymmetrical diphenylurea when heated with sulfuric acid gives a blue solution, which is evidently caused by diphenyl-
amin, for, ifølge Merck Index utgitt av Merck & Co., amine, for, according to the Merck Index published by Merck & Co.,
Inc. Rahway, N.J. (USA), 9. utgave, (1976), side Inc. Rahway, N.J. (USA), 9th ed., (1976), p
443-444 gir difenylamin en dyp blåfarge med svovelsyre. Det med den nye fremgangsmåte oppnådde tekniske fremskritt består videre i at hydrolysen ifølge oppfinnelsen i det vesentlige foregår ved værelsestemperatur, således at faren for korrosjonsbeskadigelser på anvendte metalliske reaksjonskar minskes, mens den kjente hydrolysefremgangsmåten foregår ved hjelp at mineralsyre ved tilbakeløpstemperatur hvor ved korrosjons-belastningen er øket sterkt. 443-444 diphenylamine gives a deep blue color with sulfuric acid. The technical progress achieved with the new method further consists in the fact that the hydrolysis according to the invention essentially takes place at room temperature, so that the risk of corrosion damage to the metallic reaction vessels used is reduced, while the known hydrolysis method takes place with the help of mineral acid at reflux temperature where the corrosion load is increased greatly.
Derimot fåes fremgangsmåten ifølge oppfinnelsen 10-okso-10,11-dihydro-5H-dibenz(b,f)asepin-5-karboksamid i et utbytte på 64%, referert til omsatt utgangs-material, og i god renhet. In contrast, the method according to the invention obtains 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide in a yield of 64%, referred to reacted starting material, and in good purity.
Oppfinnelsen skal forklares nærmere ved hjelp av The invention shall be explained in more detail by means of
følgende eksempel. the following example.
Eksempel Example
I en ved hjelp av et med kalsiumklorid fylt tørkerør lukket rundkolbe, omrøres blandingen av 0,5g 10-klor-5H-dibenz (b,f)asepin-5-karboksamid og 5 ml konsentrert svovelsyre (96%-ig) i 10 minutter ved væreIsestemperatur, hvoretter man får en klar gulaktig oppløsning. Omrøringen fortsettes over 76 timer ved værelsestemperatur, idet det oppstår en klar, brun oppløsning. Man heller reaksjonsblandingen på 100 g is, og 100 ml metylenklorid, adskiller den organiske fasen, vasker den vandige oppløsningen fire ganger med hver gang 80 ml metylenklorid, og vasker de forended organiske oppløsninger (480 ml) tre ganger med halvmettet vandig natriumkloridoppløsning, tørker over natriumsulfat og inndamper under nedsatt trykk til tørrhet. Stir the mixture of 0.5g of 10-chloro-5H-dibenz(b,f)azepine-5-carboxamide and 5 ml of concentrated sulfuric acid (96%) in a round flask closed using a drying tube filled with calcium chloride for 10 minutes at room temperature, after which a clear yellowish solution is obtained. Stirring is continued over 76 hours at room temperature, as a clear, brown solution is formed. The reaction mixture is poured onto 100 g of ice and 100 ml of methylene chloride, the organic phase is separated, the aqueous solution is washed four times with 80 ml of methylene chloride each time, and the finished organic solutions (480 ml) are washed three times with half-saturated aqueous sodium chloride solution, dried over sodium sulfate and evaporate under reduced pressure to dryness.
Residivet omkrystalliseres fra metylenklorid/eter, hvoretter man får ren 10-okso-11-dihydro-5H-dibenz(b,f)asepin-5-karboksamid av.smeltepunkt 213-215°C. Utbytte referert til omsatt utgangsmateriale 6 4% av det teoretiske. The residue is recrystallized from methylene chloride/ether, after which pure 10-oxo-11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide of melting point 213-215°C is obtained. Yield referred to converted starting material 6 4% of the theoretical.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH970479A CH642950A5 (en) | 1979-10-30 | 1979-10-30 | Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
Publications (3)
Publication Number | Publication Date |
---|---|
NO803229L NO803229L (en) | 1981-05-04 |
NO153368B true NO153368B (en) | 1985-11-25 |
NO153368C NO153368C (en) | 1986-03-05 |
Family
ID=4354741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO803229A NO153368C (en) | 1979-10-30 | 1980-10-29 | PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPIN-5-CARBOXAMIDE. |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS5673066A (en) |
AT (1) | AT375926B (en) |
CH (1) | CH642950A5 (en) |
DK (1) | DK457680A (en) |
ES (1) | ES8200097A1 (en) |
NO (1) | NO153368C (en) |
SE (1) | SE447106B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0112812D0 (en) * | 2001-05-25 | 2001-07-18 | Portela & Ca Sa | Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom |
GB2401605A (en) | 2003-05-12 | 2004-11-17 | Portela & Ca Sa | Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
GB2422149A (en) | 2005-01-14 | 2006-07-19 | Portela & Ca Sa | Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide |
WO2007141798A1 (en) * | 2006-06-07 | 2007-12-13 | Jubilant Organosys Limited | Process for producing oxcarbazepine via an 11-alkoxy-10-halo-dihydroiminostilbene intermediate |
-
1979
- 1979-10-30 CH CH970479A patent/CH642950A5/en not_active IP Right Cessation
-
1980
- 1980-10-28 ES ES496332A patent/ES8200097A1/en not_active Expired
- 1980-10-29 DK DK457680A patent/DK457680A/en not_active Application Discontinuation
- 1980-10-29 AT AT0531980A patent/AT375926B/en not_active IP Right Cessation
- 1980-10-29 SE SE8007597A patent/SE447106B/en not_active IP Right Cessation
- 1980-10-29 NO NO803229A patent/NO153368C/en unknown
- 1980-10-30 JP JP15152580A patent/JPS5673066A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DK457680A (en) | 1981-05-01 |
CH642950A5 (en) | 1984-05-15 |
ATA531980A (en) | 1984-02-15 |
SE8007597L (en) | 1981-05-01 |
AT375926B (en) | 1984-09-25 |
ES496332A0 (en) | 1981-10-16 |
SE447106B (en) | 1986-10-27 |
ES8200097A1 (en) | 1981-10-16 |
NO153368C (en) | 1986-03-05 |
NO803229L (en) | 1981-05-04 |
JPS5673066A (en) | 1981-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2954276C (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids | |
KR19990044234A (en) | Method for preparing quinazoline derivatives | |
US4452738A (en) | Process for the manufacture of 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,]azepine | |
NO153368B (en) | PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE | |
JPH0248548B2 (en) | ||
HU182436B (en) | Process for producing 2,3,4,5-tetrahydro-1-benzoxepine-3,5-dion derivatives | |
SU1301311A3 (en) | Method for producing derivatives of hexahydroazepine,or piperidine,or pyrrolidine (versions) | |
KR100486320B1 (en) | Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one | |
KR100856133B1 (en) | Improved process for preparing atorvastatin | |
EP0040418B1 (en) | Process for preparing an 1h-indazol-3-ylacetic acid derivative | |
JP3563424B2 (en) | Method for producing 4H-pyran-4-one | |
KR101302083B1 (en) | Method for the production of substituted 2-alkoxycarbonyl-3-aminothiophenes | |
KR0127251B1 (en) | Process for preparing of 4,4'-bischloro-methylbiphenyl | |
KR890002251B1 (en) | Process for preparing oxazole compound | |
JPS6054948B2 (en) | Method for producing aromatic amines from α,β↓-unsaturated cycloaliphatic ketoxime | |
KR100441348B1 (en) | A Method for the Preparation of 6-Morphanthridone, the Intermediate of Epinastine | |
KR850000944B1 (en) | Process for preparing 5-carbamoyl-10,11-dihydro 5h-dibenz(b,f)azepine | |
RU1797608C (en) | Process for preparing 2@-methyl-trans-decahydroquinolone-4 | |
SU1077877A1 (en) | Process for preparing methyl-derivatives of cyclohexane-1,4-dione | |
FI64373B (en) | FRAMEWORK FOR FRAMEWORK OF BASIC SUBSTITUTES ALKYLTEOFYLLINDERIVAT | |
KR100516383B1 (en) | New manufacturing process of dihydrocarbostyril derivatives | |
KR100898099B1 (en) | Process for preparation of Zaltoprofen | |
JPS607988B2 (en) | Improved synthesis method of 3-amino-5-tert-butyl isoxazole | |
JPS63216861A (en) | Production of 4-hydroxyindolines | |
KR20020073980A (en) | New preparing method of dibenzothiepin derivatives |